Total Payments
$3,201
2024 Payments
$1,083
Companies
21
Transactions
34
Medicare Patients
671
Medicare Billing
$17,018
Payment Breakdown by Category
Food & Beverage$2,449 (76.5%)
Education$752.14 (23.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,449 | 26 | 76.5% |
| Education | $752.14 | 8 | 23.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $342.87 | 4 | $0 (2024) |
| Lilly USA, LLC | $282.16 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $273.25 | 3 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $243.93 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $233.73 | 2 | $0 (2024) |
| Seagen Inc. | $161.87 | 2 | $0 (2022) |
| Pharmacyclics LLC, an AbbVie Company | $153.97 | 2 | $0 (2022) |
| Daiichi Sankyo Inc. | $138.90 | 2 | $0 (2024) |
| Sirtex Medical Inc | $125.09 | 1 | $0 (2022) |
| Genentech USA, Inc. | $125.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,083 | 11 | E.R. Squibb & Sons, L.L.C. ($131.57) |
| 2023 | $711.72 | 7 | Janssen Biotech, Inc. ($212.64) |
| 2022 | $1,022 | 11 | E.R. Squibb & Sons, L.L.C. ($211.30) |
| 2021 | $384.21 | 5 | Lilly USA, LLC ($109.81) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | PFIZER INC. | LORBRENA (Drug) | Food and Beverage | In-kind items and services | $37.44 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $123.02 | General |
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $47.25 | General |
| Category: Oncology | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $84.32 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: ONC | ||||||
| 08/13/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $102.50 | General |
| 08/01/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $119.32 | General |
| Category: Oncology | ||||||
| 05/24/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $101.40 | General |
| 05/09/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $121.62 | General |
| Category: ONCOLOGY | ||||||
| 04/03/2024 | SANOFI-AVENTIS U.S. LLC | SARCLISA (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 01/23/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 09/22/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 09/07/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $110.71 | General |
| Category: Rare Disease | ||||||
| 04/18/2023 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $70.95 | General |
| 03/23/2023 | SANOFI-AVENTIS U.S. LLC | ELITEK (Biological) | Education | In-kind items and services | $69.99 | General |
| Category: Oncology | ||||||
| 02/23/2023 | Genentech USA, Inc. | Lunsumio (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: BioOncology | ||||||
| 02/08/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $122.43 | General |
| Category: Hematology | ||||||
| 01/18/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $113.64 | General |
| Category: Oncology | ||||||
| 12/06/2022 | Astellas Pharma US Inc | PADCEV (Drug) | Food and Beverage | In-kind items and services | $52.42 | General |
| Category: Oncology | ||||||
| 09/29/2022 | Seagen Inc. | — | Education | In-kind items and services | $99.00 | General |
| 09/08/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 09/06/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $60.61 | General |
| Category: Oncology | ||||||
| 08/16/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $62.87 | General |
| Category: Oncology | ||||||
| 08/03/2022 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $125.09 | General |
| Category: Interventional Oncology | ||||||
| 08/02/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $54.97 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 432 | 1,054 | $40,449 | $9,535 |
| 2022 | 8 | 163 | 9,390 | $17,480 | $3,897 |
| 2021 | 5 | 64 | 72 | $6,729 | $2,008 |
| 2020 | 1 | 12 | 12 | $5,148 | $1,578 |
Total Patients
671
Total Services
10,528
Medicare Billing
$17,018
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 25 | $6,875 | $1,937 | 28.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 22 | 22 | $7,700 | $1,760 | 22.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 33 | 37 | $8,880 | $1,453 | 16.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 55 | 79 | $2,212 | $807.30 | 36.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 62 | 94 | $2,726 | $707.73 | 26.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 49 | 75 | $3,750 | $656.38 | 17.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 45 | 74 | $740.00 | $613.20 | 82.9% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 26 | 33 | $2,805 | $592.41 | 21.1% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 26 | 53 | $2,120 | $418.16 | 19.7% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 11 | 14 | $1,050 | $179.17 | 17.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 12 | 14 | $700.00 | $173.68 | 24.8% |
| 83550 | Iron binding capacity | Office | 2023 | 12 | 14 | $350.00 | $111.41 | 31.8% |
| 83540 | Iron level | Office | 2023 | 12 | 14 | $350.00 | $82.42 | 23.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 18 | 250 | $62.50 | $24.69 | 39.5% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 27 | 256 | $128.00 | $18.92 | 14.8% |
| Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 2022 | 14 | 9,180 | $9,180 | $1,856 | 20.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 13 | 14 | $2,865 | $590.40 | 20.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 36 | 52 | $1,144 | $398.12 | 34.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 26 | 38 | $1,064 | $395.48 | 37.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 23 | 34 | $1,700 | $308.89 | 18.2% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2022 | 16 | 28 | $1,120 | $226.67 | 20.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 24 | 33 | $330.00 | $97.56 | 29.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 11 | $77.00 | $24.34 | 31.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $5,015 | $1,546 | 30.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 19 | $950.00 | $172.71 | 18.2% |
About Michele Renze, ARNP
Michele Renze, ARNP is a Acute Care healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2014. The National Provider Identifier (NPI) number assigned to this provider is 1669879045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michele Renze, ARNP has received a total of $3,201 in payments from pharmaceutical and medical device companies, with $1,083 received in 2024. These payments were reported across 34 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,449).
As a Medicare-enrolled provider, Renze has provided services to 671 Medicare beneficiaries, totaling 10,528 services with total Medicare billing of $17,018. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Des Moines, IA
- Active Since 12/01/2014
- Last Updated 11/18/2025
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1669879045
Products in Payments
- IMBRUVICA (Drug) $313.58
- ELITEK (Biological) $231.49
- Pomalyst (Drug) $211.30
- OPDIVO (Biological) $131.57
- SIR-Spheres Microspheres (Device) $125.09
- Enhertu (Drug) $125.00
- Lunsumio (Biological) $125.00
- Vonjo (Drug) $122.43
- ELAHERE (Drug) $121.62
- Trodelvy (Drug) $121.13
- Epkinly (Drug) $119.32
- clonoSEQ (Device) $116.93
- Cabometyx (Drug) $113.80
- ERLEADA (Drug) $113.64
- ANDEXXA (Biological) $110.71
- SARCLISA (Biological) $99.95
- TUKYSA (Drug) $62.87
- PADCEV (Drug) $52.42
- LORBRENA (Drug) $37.44
- INJECTAFER (Drug) $13.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Des Moines
Samantha Bonin, Dnp, Agacnp-Bc, DNP, AGACNP-BC
Acute Care — Payments: $2,354
Acute Care $2,354
Kristel Howell, Arnp, ARNP
Acute Care — Payments: $2,090
Acute Care $2,090
Julie Schuck, A.r.n.p, A.R.N.P
Acute Care — Payments: $1,357
Acute Care $1,357
Julie Shryock, Dnp, DNP
Acute Care — Payments: $1,124
Acute Care $1,124
Gloria Miller, Arnp, ARNP
Acute Care — Payments: $797.34
Acute Care $797.34
Elizabeth Biggerstaff, Arnp, ARNP
Acute Care — Payments: $686.35
Acute Care $686.35